Melatonin triggers autophagic cell death by regulating RORC in Hodgkin lymphoma

Biomed Pharmacother. 2020 Mar:123:109811. doi: 10.1016/j.biopha.2020.109811. Epub 2020 Jan 7.

Abstract

Melatonin (Mel) has been shown to involve in many essential cell functions via modulating many signaling pathways. We for the first time investigated that Mel exerted anti-tumor activities in Hodgkin lymphoma (HL) via inhibiting cell proliferation and promoting cell apoptosis. Further study revealed that Mel treatment increased expression of LC3-II and decreased p62 proteins with the enhanced production of autolysosome, indicating it induced activation of autophagy. Nevertheless, Mel treatment together with autophagy inhibitors 3-MA or CQ exacerbated the damage effect of Mel in HL cells, which means autophagy plays a protective role in this process. Furthermore, we found Mel treatment increased the expression of G protein-coupled receptors MT2 and retinoic acid-related orphan receptors (RORs), eg. RORA, RORB and RORC. While RORC has the highest increase in Mel treated HL cells. In addition, RORC overexpression induced autophagy activation. Therefore, Mel showed tumor-suppressive role due to an increased level of RORC induced autophagy in HL.

Keywords: Autophagy; Hodgkin lymphoma (HL); Melatonin (Mel); Retinoic acid-related orphan receptors (RORs).

MeSH terms

  • Adenine / analogs & derivatives
  • Adenine / pharmacology
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Autophagic Cell Death / drug effects*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Hodgkin Disease / metabolism*
  • Hodgkin Disease / pathology*
  • Humans
  • Melatonin / pharmacology*
  • Nuclear Receptor Subfamily 1, Group F, Member 3 / metabolism*

Substances

  • Antineoplastic Agents
  • Nuclear Receptor Subfamily 1, Group F, Member 3
  • 3-methyladenine
  • Adenine
  • Melatonin